Exact Mass: 685.3256

Exact Mass Matches: 685.3256

Found 9 metabolites which its exact mass value is equals to given mass value 685.3256, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Viomycin

Tuberactinomycin B; Vinacetin A; Vioactane

C25H43N13O10 (685.3256)

A cyclic peptide antibiotic produced by the actinomycete Streptomyces puniceus, used in the treatment of tuberculosis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors

Tuberactinomycin N

C25H43N13O10 (685.3256)

3,6-diamino-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-amino-(2-amino-6-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl-(1->N3)]|Viomycin

C25H43N13O10 (685.3256)

Enviomycin

3,6-diamino-N-[(6Z)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide

C25H43N13O10 (685.3256)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C258 - Antibiotic

(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide

(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide

C25H43N13O10 (685.3256)

CID 3037981

C25H43N13O10 (685.3256)

(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide

(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide

C25H43N13O10 (685.3256)

(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid

(3s,4r)-3,6-diamino-4-hydroxy-n-[(3s,6e,9r,12s,15s)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4s)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid

C25H43N13O10 (685.3256)

3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid

3,6-diamino-4-hydroxy-n-[(3r,6z)-2,5,8,11,14-pentahydroxy-6-[(c-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-(2-imino-1,3-diazinan-4-yl)-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid

C25H43N13O10 (685.3256)